Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases

Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases

Anti-interleukin 1 agents are used successfully in colchicine-resistant or intolerant Familial Mediterranean Fever (FMF) patients. Sixty-five patients with FMF who received canakinumab treatment for at least 6 months due to colchicine resistance or intolerance between 2016 and 2020 in our department...

Full description

Bibliographic Details
Main Authors: Burcu Bozkaya Yücel, Ozlem Aydog, Hulya Nalcacioglu, Ayşegül Yılmaz
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Pediatrics
Subjects:
canakinumab
colchicine resistant
familial mediterranean fever
treatment
amyloidosis
proteinuria
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2021.710501/full

Similar Items

Similar Items